875 related articles for article (PubMed ID: 27659097)
1. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
2. Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice.
Hubert A; Bochenek ML; Schütz E; Gogiraju R; Münzel T; Schäfer K
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1683-1697. PubMed ID: 28705795
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 regulates the vascular expression of vitronectin.
Luo M; Ji Y; Luo Y; Li R; Fay WP; Wu J
J Thromb Haemost; 2017 Dec; 15(12):2451-2460. PubMed ID: 29028290
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
Riascos-Bernal DF; Chinnasamy P; Gross JN; Almonte V; Egaña-Gorroño L; Parikh D; Jayakumar S; Guo L; Sibinga NES
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):879-888. PubMed ID: 28302627
[TBL] [Abstract][Full Text] [Related]
5. Janus Kinase 3, a Novel Regulator for Smooth Muscle Proliferation and Vascular Remodeling.
Wang YC; Cui XB; Chuang YH; Chen SY
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1352-1360. PubMed ID: 28473442
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.
Redmond EM; Cullen JP; Cahill PA; Sitzmann JV; Stefansson S; Lawrence DA; Okada SS
Circulation; 2001 Jan; 103(4):597-603. PubMed ID: 11157728
[TBL] [Abstract][Full Text] [Related]
7. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator inhibitor-1 inhibits angiogenic signaling by uncoupling vascular endothelial growth factor receptor-2-αVβ3 integrin cross talk.
Wu J; Strawn TL; Luo M; Wang L; Li R; Ren M; Xia J; Zhang Z; Ma W; Luo T; Lawrence DA; Fay WP
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):111-20. PubMed ID: 25378411
[TBL] [Abstract][Full Text] [Related]
9. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
[TBL] [Abstract][Full Text] [Related]
10. CTP synthase 1, a smooth muscle-sensitive therapeutic target for effective vascular repair.
Tang R; Cui XB; Wang JN; Chen SY
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2336-44. PubMed ID: 24008161
[TBL] [Abstract][Full Text] [Related]
11. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
12. Activation of transient receptor potential vanilloid 1 accelerates re-endothelialization and inhibits neointimal formation after vascular injury.
Su L; Zhang Y; He K; Wei S; Pei H; Wang Q; Yang D; Yang Y
J Vasc Surg; 2017 Jan; 65(1):197-205.e2. PubMed ID: 26947234
[TBL] [Abstract][Full Text] [Related]
13. Mindin regulates vascular smooth muscle cell phenotype and prevents neointima formation.
Zhu LH; Huang L; Zhang X; Zhang P; Zhang SM; Guan H; Zhang Y; Zhu XY; Tian S; Deng K; Li H
Clin Sci (Lond); 2015 Jul; 129(2):129-45. PubMed ID: 25751394
[TBL] [Abstract][Full Text] [Related]
14. Oncological miR-182-3p, a Novel Smooth Muscle Cell Phenotype Modulator, Evidences From Model Rats and Patients.
Sun L; Bai Y; Zhao R; Sun T; Cao R; Wang F; He G; Zhang W; Chen Y; Ye P; Du G
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1386-97. PubMed ID: 27199451
[TBL] [Abstract][Full Text] [Related]
15. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
[TBL] [Abstract][Full Text] [Related]
16. The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia.
Stiber JA; Wu JH; Zhang L; Nepliouev I; Zhang ZS; Bryson VG; Brian L; Bentley RC; Gordon-Weeks PR; Rosenberg PB; Freedman NJ
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):984-93. PubMed ID: 27013612
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor expression in artery wall and neointimal region after vascular injury.
Lee KM; Lee HJ; Kim MK; Kim HS; Jung GS; Hur SH; Kim HT; Cho WH; Kim JG; Kim BW; Lim JO; Choi HS; Lee KU; Park KG; Lee IK
Atherosclerosis; 2009 Dec; 207(2):391-8. PubMed ID: 19586629
[TBL] [Abstract][Full Text] [Related]
18. Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM; Prock A; Dutzmann J; Sonnenschein K; Thum T; Bauersachs J; Sedding DG
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):317-27. PubMed ID: 26663397
[TBL] [Abstract][Full Text] [Related]
19. The effect of endothelial cell overexpression of plasminogen activator inhibitor-1 on smooth muscle cell migration.
Proia RR; Nelson PR; Mulligan-Kehoe MJ; Wagner RJ; Kehas AJ; Powell RJ
J Vasc Surg; 2002 Jul; 36(1):164-71. PubMed ID: 12096275
[TBL] [Abstract][Full Text] [Related]
20. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway.
Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X
Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
